…
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
International Flavors & Fragrances (IFF) supplies flavors, fragrances and ingredient solutions to food, beverage, personal-care and household manufacturers. Long-term growth drivers include rising demand for natural and sustainable ingredients, innovation in bioscience-derived solutions, and expansion in emerging markets, which may benefit from the company's scale. Investors may value the diversified customer base and leading market position.
Principal risks are raw-material price volatility, regulatory and allergen scrutiny, intensive competition from global peers and execution or integration risk from strategic transactions.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -412.00M | 278.00M | -2518.00M | -1625.00M | 354.00M |
| Minority interest | -2.00M | -4.00M | -5.00M | -7.00M | -9.00M |
| Net income | -361.00M | 243.00M | -2565.00M | -1836.00M | 270.00M |
| Selling general administrative | 1834.00M | 1995.00M | 1783.00M | 1768.00M | 1749.00M |
| Gross profit | 3938.00M | 4124.00M | 3681.00M | 4151.00M | 3735.00M |
| Reconciled depreciation | 962.00M | 1015.00M | 1137.00M | 1179.00M | 1156.00M |
| Ebit | -183.00M | 583.00M | -2138.00M | 1090.00M | 585.00M |
| Ebitda | 779.00M | 1598.00M | -996.00M | 2269.00M | 1839.00M |
| Depreciation and amortization | 962.00M | 1015.00M | 1142.00M | 1179.00M | 1254.00M |
| Non operating income net other | - | - | - | - | 58.00M |
| Operating income | 842.00M | 766.00M | -2110.00M | 1090.00M | 585.00M |
| Other operating expenses | 10048.00M | 10718.00M | 13589.00M | 11387.00M | 11031.00M |
| Interest expense | 229.00M | 305.00M | 380.00M | 336.00M | 289.00M |
| Tax provision | -39.00M | 31.00M | 96.00M | 211.00M | 75.00M |
| Interest income | 229.00M | 381.00M | 452.00M | 336.00M | 289.00M |
| Net interest income | -229.00M | -305.00M | -441.00M | -336.00M | -289.00M |
| Extraordinary items | 1.00M | - | - | - | - |
| Non recurring | - | - | - | - | -1.00M |
| Income tax expense | -53.00M | 31.00M | 45.00M | 211.00M | 75.00M |
| Total revenue | 10890.00M | 11484.00M | 11479.00M | 12440.00M | 11656.00M |
| Total operating expenses | 3096.00M | 3358.00M | 5791.00M | 3098.00M | 3110.00M |
| Cost of revenue | 6952.00M | 7360.00M | 7798.00M | 8289.00M | 7921.00M |
| Total other income expense net | -1254.00M | -488.00M | -408.00M | -2715.00M | -231.00M |
| Net income from continuing ops | -359.00M | 247.00M | 22.00M | -1836.00M | 279.00M |
| Net income applicable to common shares | -374.00M | 243.00M | -2565.00M | -1868.00M | 270.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 25539.00M | 28667.00M | 30978.00M | 35390.00M | 39678.00M |
| Intangible assets | 6043.00M | 6445.00M | 8357.00M | 9082.00M | 10506.00M |
| Other current assets | 639.00M | 3299.00M | 861.00M | 1970.00M | 1850.00M |
| Total liab | 11353.00M | 14756.00M | 16336.00M | 17597.00M | 18455.00M |
| Total stockholder equity | 14154.00M | 13876.00M | 14611.00M | 17734.00M | 21118.00M |
| Deferred long term liab | - | - | - | - | 2518.00M |
| Other current liab | 1288.00M | 1366.00M | 1216.00M | -542.00M | 3001.00M |
| Common stock | 35.00M | 35.00M | 35.00M | 35.00M | 35.00M |
| Capital stock | 35.00M | 35.00M | 35.00M | 35.00M | 35.00M |
| Retained earnings | -3417.00M | -2605.00M | -2439.00M | 955.00M | 3641.00M |
| Other liab | - | - | - | 2956.00M | 4054.00M |
| Good will | 8269.00M | 9080.00M | 10635.00M | 13355.00M | 16414.00M |
| Other assets | 1602.00M | 629.00M | 727.00M | 667.00M | 1383.00M |
| Cash | 590.00M | 469.00M | 703.00M | 493.00M | 715.00M |
| Cash and equivalents | 590.00M | 469.00M | 703.00M | 483.00M | 711.00M |
| Total current liabilities | 3933.00M | 4333.00M | 3758.00M | 3738.00M | 3633.00M |
| Current deferred revenue | - | - | 401.00M | 2265.00M | -1532.00M |
| Net debt | 6061.00M | 9152.00M | 10114.00M | 10477.00M | 10685.00M |
| Short term debt | 1358.00M | 1495.00M | 970.00M | 597.00M | 632.00M |
| Short long term debt | 1254.00M | 1413.00M | 885.00M | 597.00M | 632.00M |
| Short long term debt total | 6651.00M | 9621.00M | 10823.00M | 10970.00M | 11400.00M |
| Other stockholder equity | 18966.00M | 18973.00M | 18911.00M | 18913.00M | 18865.00M |
| Property plant equipment | 4029.00M | 4339.00M | 4955.00M | 4861.00M | 4368.00M |
| Total current assets | 5594.00M | 7993.00M | 6293.00M | 7432.00M | 6987.00M |
| Long term investments | 15.00M | 10.00M | 11.00M | 10.00M | 86.00M |
| Net tangible assets | - | - | - | -4753.00M | -5822.00M |
| Net receivables | 2001.00M | 1969.00M | 2091.00M | 1818.00M | 1906.00M |
| Long term debt | 4740.00M | 7564.00M | 9186.00M | 10373.00M | 10768.00M |
| Inventory | 2364.00M | 2256.00M | 2638.00M | 3151.00M | 2516.00M |
| Accounts payable | 1287.00M | 1283.00M | 1378.00M | 1418.00M | 1532.00M |
| Noncontrolling interest in consolidated entity | - | - | - | - | 35.00M |
| Accumulated other comprehensive income | -1430.00M | -2527.00M | -1896.00M | -2169.00M | -1423.00M |
| Common stock total equity | - | - | - | - | 35.00M |
| Retained earnings total equity | - | - | - | - | 3641.00M |
| Treasury stock | - | - | - | - | -997.00M |
| Non currrent assets other | 693.00M | 560.00M | 449.00M | 1150.00M | 1215.00M |
| Non current assets total | 19945.00M | 20674.00M | 24685.00M | 27958.00M | 32691.00M |
| Capital lease obligations | 625.00M | 616.00M | 727.00M | 651.00M | 784.00M |
| Long term debt total | 4740.00M | 7582.00M | 9204.00M | 10385.00M | 10768.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 105.00M | 326.00M | 496.00M | 745.00M | -18.00M |
| Change to liabilities | - | - | - | -57.00M | 419.00M |
| Total cashflows from investing activities | 2269.00M | 326.00M | 574.00M | 745.00M | -18.00M |
| Net borrowings | -2599.00M | -1030.00M | -941.00M | -344.00M | -606.00M |
| Total cash from financing activities | -3091.00M | -1606.00M | -1851.00M | -1229.00M | -1304.00M |
| Change to operating activities | - | - | - | 17.00M | -40.00M |
| Net income | -359.00M | 247.00M | -2563.00M | -1836.00M | 279.00M |
| Change in cash | 119.00M | -240.00M | 216.00M | -216.00M | 56.00M |
| Begin period cash flow | 471.00M | 709.00M | 493.00M | 716.00M | 660.00M |
| End period cash flow | 590.00M | 469.00M | 709.00M | 500.00M | 716.00M |
| Total cash from operating activities | 850.00M | 1070.00M | 1439.00M | 345.00M | 1437.00M |
| Depreciation | 962.00M | 1015.00M | 1142.00M | 1179.00M | 1156.00M |
| Other cashflows from investing activities | 105.00M | 16.00M | 27.00M | 1251.00M | 379.00M |
| Dividends paid | 409.00M | 514.00M | 826.00M | 810.00M | 667.00M |
| Change to inventory | -41.00M | -34.00M | 605.00M | -893.00M | -363.00M |
| Change to account receivables | -68.00M | -217.00M | 51.00M | -117.00M | -169.00M |
| Sale purchase of stock | -38.00M | -16.00M | -13.00M | 0.00M | -9.00M |
| Other cashflows from financing activities | -45.00M | -46.00M | -84.00M | 302.00M | 296.00M |
| Change to netincome | - | - | - | 2139.00M | 164.00M |
| Capital expenditures | 594.00M | 468.00M | 503.00M | 506.00M | 397.00M |
| Change receivables | - | - | - | - | -169.00M |
| Cash flows other operating | - | - | - | - | 235.00M |
| Exchange rate changes | - | - | - | - | -59.00M |
| Cash and cash equivalents changes | - | - | - | - | 56.00M |
| Change in working capital | -421.00M | -115.00M | 485.00M | -1073.00M | -153.00M |
| Stock based compensation | 88.00M | 77.00M | 65.00M | 49.00M | 54.00M |
| Other non cash items | 850.00M | 150.00M | 2679.00M | 2320.00M | 337.00M |
| Free cash flow | 256.00M | 602.00M | 936.00M | -161.00M | 1040.00M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| IFF International Flavors & Fragrances Inc |
-3.74 4.33% |
82.62 | - | 17.21 | 1.99 | 1.52 | 2.50 | 59.00 |
| LIN Linde plc Ordinary Shares |
-5.98 1.15% |
515.25 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.75 1.77% |
41.68 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
0.00 0.00% |
211.18 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-4.96 1.42% |
344.05 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
521 West 57th Street, New York, NY, United States, 10019-2960
212 765 5500
21500
| Name | Title | Year Born |
|---|---|---|
| Mr. Glenn Robert Richter | Exec. VP & CFO | 1962 |
| Mr. Nicolas Mirzayantz | Pres of Nourish | 1963 |
| Mr. Franklin K. Clyburn Jr. | CEO & Director | 1965 |
| Mr. Ralf Finzel | Exec. VP & Global Operations Officer | NA |
| Ms. Beril Yildiz | Sr. VP & Chief Accounting Officer | 1978 |
| Mr. Vic Verma | Exec. VP & Chief Information Officer | 1969 |
| Mr. Michael DeVeau | Sr. VP and Chief Investor Relations & Communications Officer | 1981 |
| Dr. Jennifer Amy Johnson Ph.D. | Exec. VP & Gen. Counsel | 1975 |
| Ms. Deborah Borg | Chief HR and Diversity, Equity & Inclusion Officer | 1977 |
| Dr. Gregory Yep | Exec. VP and Chief R&D, Global Integrated Solutions & Sustainability Officer | 1965 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.